for its lead product candidate BMF-219, and that the United States Adopted Name Council has adopted “icovamenib” as the United States Adopted Name (USAN) for BMF-219. The suffix ‘-menib ...

Biomea Fusion (BMEA) announced that the World Health Organization, WHO, has approved “icovamenib” as the International Nonproprietary Name, INN, for its lead product candidate BMF-219 ...

Biomea Fusion’s stock is on the up after the company plans to resume two clinical trials evaluating its therapy for type 1 ...

International diabetes pioneers and thought leaders from 11 countries will work with Biomea leadership to unlock the potential of menin science and beta cell biology to advance BMF-219 and Biomea ...

for its lead product candidate BMF-219, and that the United States Adopted Name Council has adopted “icovamenib” as the United States Adopted Name (USAN) for BMF-219. The suffix ‘-menib ...

Any such statements in this press release that are not statements of historical fact, including statements regarding the clinical and therapeutic potential of our product candidates and development ...

Any such statements in this press release that are not statements of historical fact, including statements regarding the clinical and therapeutic potential of our product candidates and development ...